Contribution of age to clinical trial enrollment and tolerance with ovarian cancer.

Jessica Gillen,Camille Gunderson,Molly Greenwade,Michelle Rowland,Rachel Ruskin,Kai Ding,Aleia Crim,Adam Walter, Emily White,Kathleen Moore

Gynecologic Oncology（2017）

引用 7|浏览16

暂无评分

摘要

•Older patients with ovarian cancer are less likely to enroll on clinical trial.•Women≥70 tolerated chemotherapy on trial as well as their younger counterparts•Age≥70 is an independent predictor of shorter overall survival in ovarian cancer.

查看译文

关键词

Ovarian cancer,Chemotherapy tolerance,Older women

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要